These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17137606)
1. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex. Yoshikawa Y; Adachi Y; Sakurai H Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606 [TBL] [Abstract][Full Text] [Related]
2. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Adachi Y; Yoshida J; Kodera Y; Kiss T; Jakusch T; Enyedy EA; Yoshikawa Y; Sakurai H Biochem Biophys Res Commun; 2006 Dec; 351(1):165-70. PubMed ID: 17052688 [TBL] [Abstract][Full Text] [Related]
3. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus. Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860 [TBL] [Abstract][Full Text] [Related]
4. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice. Saha TK; Yoshikawa Y; Sakurai H ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806 [TBL] [Abstract][Full Text] [Related]
5. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies. Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542 [TBL] [Abstract][Full Text] [Related]
6. The pharmacology of the insulinomimetic effect of zinc complexes. Sakurai H; Adachi Y Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223 [TBL] [Abstract][Full Text] [Related]
7. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes. Yoshikawa Y; Kondo M; Sakurai H; Kojima Y J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760 [TBL] [Abstract][Full Text] [Related]
8. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid. Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500 [TBL] [Abstract][Full Text] [Related]
9. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice. Karmaker S; Saha TK; Yoshikawa Y; Sakurai H Macromol Biosci; 2009 Mar; 9(3):279-86. PubMed ID: 18989849 [TBL] [Abstract][Full Text] [Related]
10. Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes. Yoshikawa Y; Adachi Y; Yasui H; Hattori M; Sakurai H Chem Pharm Bull (Tokyo); 2011; 59(8):972-7. PubMed ID: 21804241 [TBL] [Abstract][Full Text] [Related]
11. Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex. Karmaker S; Saha TK; Yoshikawa Y; Sakurai H ChemMedChem; 2007 Nov; 2(11):1607-12. PubMed ID: 17768733 [TBL] [Abstract][Full Text] [Related]
12. Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex. Adachi Y; Yoshikawa Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H Biochem Biophys Res Commun; 2006 Jul; 345(3):945-50. PubMed ID: 16707105 [TBL] [Abstract][Full Text] [Related]
13. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities. Adachi Y; Yoshikawa Y; Sakurai H Biofactors; 2007; 29(4):213-23. PubMed ID: 18057552 [TBL] [Abstract][Full Text] [Related]
14. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes. Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407 [TBL] [Abstract][Full Text] [Related]
15. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes. Yoshikawa Y; Ueda E; Kojima Y; Sakurai H Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182 [TBL] [Abstract][Full Text] [Related]
16. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities. Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366 [TBL] [Abstract][Full Text] [Related]
17. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats. Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728 [TBL] [Abstract][Full Text] [Related]
18. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV). Sakurai H; Fujii K; Watanabe H; Tamura H Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515 [TBL] [Abstract][Full Text] [Related]
19. Effects of chronic acarbose treatment on adipocyte insulin responsiveness, serum levels of leptin and adiponectin and hypothalamic NPY expression in obese diabetic Wistar rats. Pérez C; Fernández-Agulló T; De Solís AJ; Ros M; Andrés A; Carrascosa JM Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):256-61. PubMed ID: 18290871 [TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice. Itoh T; Kobayashi M; Horio F; Furuichi Y Nutrition; 2009 Feb; 25(2):134-41. PubMed ID: 18929464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]